Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer - Drug Trials For Money - Paid Clinical Trials

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer
Conditions:   Prostate Cancer;   Stage IV Prostate Cancer
Interventions:   Drug: Luteinizing Hormone Releasing Hormone;   Drug: New Hormonal Agent;   Drug: Docetaxel;   Drug: Tislelizumab
Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   BeiGene
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 13, 2022 / by / in
Comments